跳转至内容
Merck
CN
  • Genetic engineering of untransformable coagulase-negative staphylococcal pathogens.

Genetic engineering of untransformable coagulase-negative staphylococcal pathogens.

Nature protocols (2016-04-23)
Volker Winstel, Petra Kühner, Holger Rohde, Andreas Peschel
摘要

Coagulase-negative staphylococci (CoNS) are recognized as significant opportunistic pathogens. However, current knowledge of virulence mechanisms is very limited because a significant proportion of CoNS are refractory to available techniques for DNA transformation. We describe an efficient protocol for plasmid transfer using bacteriophage Φ187, which can transduce plasmid DNA to a wide range of CoNS from a unique, engineered Staphylococcus aureus strain. The use of a restriction-deficient, modification-proficient S. aureus PS187 mutant, which has a CoNS-type bacteriophage surface receptor, allows plasmid transfer to CoNS even when they are refractory to electroporation. Once the Φ187 titer reaches 10(9) plaque-forming units per milliliter, plasmid transfer can be accomplished within 1-2 d. Thus, our protocol is a major technical advance offering attractive opportunities for research on CoNS-mediated infections.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
溶葡球菌酶 来源于溶葡萄球菌, lyophilized powder, Protein 50-70 % by biuret, ≥500 units/mg protein